Agency classClass IIOur severity:Severe FDA (Drugs)·D-0882-2018·Announced 2018-06-27

ICU Medical Recalls Sodium Chloride Injection Bags Due to Sterility Concerns

ICU Medical is recalling 941,496 bags of 0.9% Sodium Chloride Injection due to a lack of assurance of sterility and potential for leaking.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.

Plain-English summary

ICU Medical Inc. is recalling 941,496 bags of 0.9% Sodium Chloride Injection, USP, 250 mL bag, Rx Only. The product is identified by NDC 0409-7983-02 and includes Lot # 85-018-JT and 85-031-JT with an expiration date of 01/01/2020. The recall was initiated because the bags have the potential to leak, resulting in a lack of assurance of sterility.

The affected products were distributed nationwide and in Canada. This recall is classified as Class II by the U.S. Food and Drug Administration. The source text does not report any specific illnesses or injuries associated with the use of these products.

Healthcare providers and consumers should stop using the affected lots immediately and contact their supplier or the recalling firm for further instructions on how to return or dispose of the product.

The recalled product

Product: 0.9% Sodium Chloride Injection, USP, 250 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7983-02
Manufacturer: ICU Medical Inc
Category: Drug — Injectable Solution
Hazard: sterility
leakage
Affected units: 941,496

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

Lot #: 85-018-JT
85-031-JT
Exp. 01/01/2020

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 5 recalled by ICU Medical Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →

Same manufacturer · ICU Medical Inc

See all →

High
ICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
High
ICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
High
ICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Moderate
ICU Medical Recalls IV Administration Sets with Drip Chamber Specks
FDA (Devices) · 2026-09-23
Moderate
ICU Medical Recalls Oncology Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23

Same hazard · sterility